Skip to main content

Our company
About Us

About Nestle Health Science
Key Investments
Leadership team
Health Management
Aging

Healthy aging
Malnutrition

Brain Health

Alzheimers
Epilepsy

Cancer/Oncology

Cancer/Oncology
My Cancer Nutrition

Critical care/Surgery

Adult Enteral Nutrition
Critical Nutrition Bytes
Major Surgery
Target Nutrition App
Nutrition monitoring in the ICU

Dysphagia

Dysphagia

Food Allergy

Cow's Milk Protein Allergy

Gastro Intenstinal

Constipation
Inflammatory bowel disease
Irritable bowel syndrome

Metabolic disease

Inborn errors of metabolism

Metabolic Health

Weight management

Pediatrics

Cystic fibrosis
Failure to thrive / growth delay
GI impairment
My child with Cerebral Palsy
Neurological disorders
Our Brands

Filter brands for:
Choose Therapies

Filter By

All

Tube feeding

Pediatrics

Adult nutrition

Diabetes
Newsroom
Press Releases
Events
Videos

Search

Search

Press enter to search

Nestlé Health Science
Health management
Gastro intestinal

Gastro intestinal

IRRITABLE BOWEL SYNDROME

INFLAMMATORY BOWEL DISEASE

The following content is restricted for healthcare professional only. You will be redirected.

Nestlé Health Science - Global headquarters

Mailing address: Avenue Nestlé 55, 1800 Vevey, Switzerland

You are in the global site: Change Location

Legal

Search
Site map
Terms & Conditions
Privacy & Cookie Policy
Contact Us
Careers
Cookie consent

Follow Us

Linkedin Twitter YouTube

© Nestlé Health Science 2020 - All rights reserved

Our Company
- About Us
Health Management
Our Brands
- Althéra - Alfaré - Alfamino
- Boost
- Impact
- Isosource
- Meritene
- Modulen
- Novasource
- Nutren
- OptiFibre
- Optifast
- Peptamen
- Resource® ThickenUp®
- Resource®
- Sustagen
- Vitaflo
Newsroom